High Efficiency Aromatic Synthesis Icon
The PKS pathway offers a direct, high-yield route to the tri-hydroxylated aromatic structure of Phloroglucinol.
Phloroglucinol is a valuable aromatic compound used as a Bio-monomers Resins/Dyes precursor for producing high-performance resins, UV absorbers, and pharmaceuticals. Its current supply chain faces significant limitations: Low yield and high cost of natural extraction from sources like algae or plants, and the alternative complex chemical synthesis route is inefficient. This necessitates a more sustainable and high-yield biomanufacturing method.
CD Biosynsis offers an advanced metabolic engineering platform for Phloroglucinol production: Metabolic Engineering: Engineer E. coli or yeast to biosynthesize Phloroglucinol from Malonyl-CoA and Acetyl-CoA via the Polyketide Synthase PKS pathway. This route is highly efficient, starting from cheap sugars. We optimize the biosynthetic cascade by focusing on: Overexpression of key PKS components and Cyclase enzymes. Maximizing the activity of the Polyketide Synthase and the downstream Cyclase is essential for high titer production and purity.
Get a QuoteThe supply chain for Phloroglucinol faces these key hurdles:
A bio-based approach must ensure high precursor supply and efficient conversion by the PKS enzyme system.
CD Biosynsis utilizes advanced metabolic and enzyme engineering to optimize Phloroglucinol production:
PKS Pathway Integration
We integrate the full PKS pathway e.g. TKS, PKS III into robust industrial hosts like E. coli or Y. lipolytica to convert simple carbon sources into Phloroglucinol.
PKS and Cyclase Overexpression
We overexpress the key PKS and Cyclase enzymes that form the final aromatic ring structure, utilizing strong, constitutive promoters to maximize their activity and overcome the rate-limiting steps.
Precursor Flux Enhancement
We engineer the central metabolism by enhancing the activity of Acetyl-CoA carboxylase and other upstream enzymes to ensure an ample and balanced supply of Malonyl-CoA and Acetyl-CoA precursors.
Byproduct Pathway Minimization
We use targeted gene deletion to eliminate competing metabolic pathways that divert carbon away from the PKS route, thereby maximizing the overall carbon yield for Phloroglucinol.
This approach establishes a high-yield, pure, and continuous supply chain for Phloroglucinol from simple sugars.
Our Phloroglucinol engineering service is dedicated to pursuing the following production goals:
High Efficiency Aromatic Synthesis Icon
The PKS pathway offers a direct, high-yield route to the tri-hydroxylated aromatic structure of Phloroglucinol.
Avoid Complex Chemical Steps Icon
Bioproduction eliminates the need for the costly, low-yield multi-step chemical synthesis or natural extraction.
Maximize Precursor Availability Icon
Metabolic engineering ensures high availability of the Malonyl-CoA building block for the PKS route.
Robust Microbial Platform Icon
Engineered E. coli and yeast are scalable, fast-growing hosts ideal for industrial fermentation.
High Product Purity Icon
The specificity of the PKS enzyme cascade minimizes the formation of undesirable structural analogs.
We deliver a sustainable, high-titer cell factory for the production of Phloroglucinol and its derivatives.
Our Phloroglucinol strain engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product quality attributes.
Explore the potential for a sustainable, high-titer Phloroglucinol supply. CD Biosynsis provides customized strain and process engineering solutions:
Why is Malonyl-CoA precursor supply the key challenge?
The Polyketide Synthase pathway requires large amounts of Malonyl-CoA as a direct building block. In native hosts, this molecule is usually tightly regulated for fatty acid synthesis. Redirecting enough carbon flux from the central metabolism to overcome this limitation and supply the PKS pathway is the primary metabolic engineering challenge for high Phloroglucinol yield.
What is the advantage of using the PKS pathway?
The Polyketide Synthase PKS pathway is highly versatile and naturally produces complex, highly functionalized aromatic molecules. For Phloroglucinol, it offers a shorter, more specific biosynthetic route from simple C2 units Acetyl-CoA to the C6 aromatic ring, bypassing the complex, low-yield steps of traditional chemical synthesis.
How is low enzyme activity of PKS and Cyclase overcome?
We use strong, optimized promoters to achieve high copy numbers of the PKS and Cyclase enzymes. Additionally, codon optimization ensures efficient translation in the host. If necessary, directed evolution or site-directed mutagenesis is employed to improve the specific activity, stability, and affinity of the enzymes for their substrates.
What makes natural extraction from plants/algae economically unviable?
Natural sources contain Phloroglucinol at very low concentrations, requiring large volumes of biomass and extensive, energy-intensive separation and purification steps. This makes the final product extremely costly and subjects the supply to seasonal and geographical variability, unlike the consistent, high-titer production achievable in a bioreactor.
What is the estimated project timeline?
A comprehensive project involving precursor pathway engineering, PKS integration, and fermentation optimization typically requires 26-34 weeks for final strain delivery and validated high-titer bioconversion protocol.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.